Calmoseptine, Inc.   Report issue

For profit Phase 3 Phase 4
Founded: Huntington Beach CA United States (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
2012
NCT02080247
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

zinc (1 trial)

zinc oxide (2 trials)

Drugs in Phase 3 Trials (1)

zinc dichloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Diaper Rash (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3